Zevia’s (NYSE:ZVIA) Q2 CY2026 Sales Beat Estimates, Next Quarter’s Sales Guidance is Optimistic

Zevia (NYSE:ZVIA) reported Q2 CY2026 revenue of $45M, up 1.1% year over year and above Wall Street estimates. Management guided next-quarter revenue near $45M, about 2.2% above analyst forecasts. GAAP EPS loss was $0.04, $0.01 better than consensus. Free cash flow was $2.19M and turned positive.

Original reporting
Published Aug 5, 2026, 8:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 5, 2026, 9:30 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Zevia’s (NYSE:ZVIA) Q2 CY2026 Sales Beat Estimates, Next Quarter’s Sales Guidance is Optimistic — source image
Decision brief

The 30-second read

$ZVIABullishMed
01

Why it matters

Q2 revenue beat and a next-quarter revenue guide above consensus are actionable for traders managing near-term expectations, but the immediate 2.3% stock drop suggests investors weighed other guidance items (notably full-year revenue) and/or cash-flow durability.

02

Market read

This is a guidance-driven earnings update with specific revenue and EPS figures, plus a noted immediate negative tape reaction despite the beat.

03

What to watch

Free cash flow is small in absolute terms ($2.19M in Q2) and the article notes trailing-12-month revenue has been flat versus three years ago, which can cap multiple expansion.

Relevance 7/10Novelty 6/10Timing: after-hours/pre-market positioning following Q2 results and next-quarter guidance

Background

Zevia is a better-for-you beverage company focused on soda, with additional energy drink and tea offerings.

Company-level read

Ticker impact

$ZVIABullishMedium confidence
Context

Zevia reported Q2 CY2026 revenue of $45M, beat estimates, and guided next-quarter revenue to about $45M, 2.2% above consensus.

Expected impact

Likely supports a near-term re-rating attempt, but follow-through depends on whether investors focus on the revenue guide versus other misses (full-year revenue guidance).

Evidence & confidence

The article provides specific Q2 results, next-quarter revenue guidance, and notes immediate post-results downside, implying mixed market interpretation rather than a clean upside reaction.

Market effects

Signals modest demand resilience for a better-for-you beverage niche, but does not change broader sector fundamentals.

No specific regional impact described beyond US-listed consumer staples sentiment.

No global macro or international supply-chain developments mentioned.

Counterpoint

The guidance optimism may be offset by weaker full-year revenue guidance and limited free-cash-flow scale, so the market may be discounting sustainability.

Key entities

  • Zevia

    NYSE-listed beverage company reporting Q2 CY2026 results and providing next-quarter revenue and EBITDA-related guidance.

Related articles

$ZVIAHigh

Zevia PBC (ZVIA): Results of Operations and Financial Condition

Zevia PBC (ZVIA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_974482.htm EXHIBIT 99.1 ex_974482.htm Exhibit 99.1 Zevia Announces Second Quarter 2026 Results Net Sales at the High End of Outlook; Adjusted EBITDA Exceeds Outlook LOS ANGELES – August 5, 2026 (BUSINESS WIRE) – Zevia PBC (“Zevia” or the “Company”) (NYSE: ZVIA), the

$ZVIAMedAI 8/10

Zevia Appoints Brian Bousley as Chief Commercial Officer

Zevia PBC (NYSE: ZVIA) appointed Brian Bousley as Executive Vice President and Chief Commercial Officer, effective immediately. He will lead sales, distribution and category management, reporting to CEO Amy Taylor. Zevia said Bousley brings 25+ years in beverages, including CCO roles at Yerba Madre and prior leadership at Pabst Brewing and Red Bull.

$WHRMed

Whirlpool Q2 Earnings Call Highlights

Whirlpool (NYSE:WHR) reported Q2 earnings call updates. North America industry demand fell 3.4% YoY, but Whirlpool said it held market share. The company raised promotional pricing by over 10% in late April and expects further margin improvement in Q3. It targets $150M cost reductions in 2026, including $60M automation, and guided FY revenue up ~1.5% and FCF of ~$300M.

$WATMedAI 8/10

Waters Q2 Earnings Call Highlights

Waters (NYSE:WAT) reported Q2 updates from its earnings call. Materials Science Division revenue rose to $87M. Biosciences and Diagnostic Solutions acquired from BD generated $817M revenue. Waters raised FY organic constant-currency growth outlook to 7% to 9%, projecting FY reported revenue of $3.370B to $3.431B and adjusted EPS of $14.45 to $14.65.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$WMedAI 8/10

Wayfair Q2 Earnings Call Highlights

Wayfair (NYSE:W) said Q2 new-order growth accelerated for a fourth straight quarter to a post-COVID high, citing U.S. gains from pricing, selection, delivery speed and availability, plus initiatives like Wayfair Rewards and stores. Q3 revenue growth is forecast at high-single digits. Perigold sales grew over 35% YoY and exceeded $400M annual. Q2 gross margin was 30.0%, adjusted EBITDA $242M, and free cash flow $301M. The company issued $400M notes to redeem 2028 converts.